Gold preparations

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 30.09.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Antirheumatic drugs, basic therapeutics. For example, auranofin, sodium aurothiomalate.

IndicationThis section has been translated automatically.

Psoriatic arthritis, rheumatoid arthritis.

Notice! Before starting therapy, pregnancy must be ruled out and effective contraception must be carried out during therapy!

Limited indicationThis section has been translated automatically.

Insulin-dependent diabetes mellitus, sun exposure (including artificial UV radiation).

Undesirable effectsThis section has been translated automatically.

See Table 1.

InteractionsThis section has been translated automatically.

See Table 2.

ContraindicationThis section has been translated automatically.

Pregnancy, lactation, agranulocytosis, atopic diathesis, autoimmune diseases (dermatomyositis, systemic lupus erythematosus, scleroderma), haematopoietic disorders, bleeding tendency, ulcerative colitis, severe liver and kidney dysfunction, thrombocytopenia, active pulmonary tuberculosis, hypersensitivity to heavy metals.

TablesThis section has been translated automatically.

Side effects of gold preparations

Airways

allergic alveolitis, bronchiolitis, interstitial pulmonary fibrosis (under therapy 1 time/year X-ray control of the thorax!)

blood, lymph

Agranulocytosis, hypo- to aplastic or hemolytic anemia,

Eosinophilia (therapy discontinuation in > 12%)

Leukopenia, neutropenia, thrombocytopenia (discontinuation of therapy if < 100,000 platelets/μl), pancytopenia,

thrombocytopenic purpura

GIT

Loss of appetite, vomiting, diarrhea

Cholestasis, jaundice, hepatitis

Gastrointestinal bleeding

Transaminase elevations, rarely hepatic necrosis

Urinary tract

Albuminuria, hematuria, proteinuria (discontinuation of therapy at > 300 mg protein/l urine), cylindruria

Glomerulonephritis, immune complex nephritis

gold nephropathy, tubular necrosis

acute renal failure

Skin

allergic exanthema, pityriasis rosea-like reactions, pruritus, alopecia, Quincke's edema, anaphylactic shock, Lyell's syndrome

gingivitis, stomatitis

Photosensitization

gray-blue pigmentation, especially in light-exposed areas

intradermal gold deposits

drug-induced lupus erythematosus

onycholysis, hyperhidrosis

Cardiovascular

bradycardia, tachyarrhythmia

Nervous system

EEG changes, headache, seizures, hallucinations, confusional states

Encephalopathy, encephalitis, neuropathy, neuritis

Guillain-Barré syndrome

Sensory organs

metallic taste

Chrysiasis (gold deposits in eye tissue)

corneal ulcers

iritis, conjunctivitis, neuritis optic nerves

supporting apparatus

Arthralgias

Pain at the injection site in case of i.m. application Application

Significant interactions of gold preparations

Butazone

Reciprocal toxicity ↑, avoid combination.

Chloroquine

Retinopathy risk ↑.

Clozapine

Agranulocytosis, avoid combination

Iron

Gold effect with oral administration ↓

Metamizole

reciprocal toxicity ↑, avoid combination

NSAIDS

Blood formation disorders, mutual toxicity ↑.

Penicillamine

Blood formation disorders, kidney damage, gold effect ↓, avoid combination

Cytostatics

mutual toxicity ↑, avoid combination

Authors

Last updated on: 30.09.2022